Alcuronium


Generic Medicine Info
Indications and Dosage
Intravenous
Endotracheal intubation, Muscle relaxant in general anaesthesia
Adult: Initially, 150-250 mcg/kg; additional doses of 30 mcg/kg may be given as needed.
Contraindications
Porphyria.
Special Precautions
Caution when used in renal impairment due to prolonged elimination half-life. Monitor the degree of block to prevent overdosage.
Adverse Reactions
Tachycardia and hypotension.
Potentially Fatal: Anaphylactic reactions.
Action
Description:
Mechanism of Action: Alcuronium chloride is a benzylisoquinolinium competitive neuromuscular blocker. It is used for endotracheal intubation and to produce muscle relaxation in general anaesthesia during surgical procedures.
Onset: About 2 minutes.
Duration: 20-30 minutes.
MIMS Class
Neuromuscular Blocking Agents
Disclaimer: This information is independently developed by MIMS based on Alcuronium from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in